ENTA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 13.64%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $504,129.74

Enanta Pharmaceuticals Insider Trading History Chart

Enanta Pharmaceuticals Share Price & Price History

^$15.52

▲ +0.19 (1.24%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

625,000% Gain

From Crypto Swap Profits | Ad

Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.

>> Dive into the Workshop Here

Enanta Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/15/2024	Scott T Rottinghaus	Insider	Sell	5,375	$17.08	$91,805.00	21,717
7/11/2024	Scott T Rottinghaus	Insider	Sell	4,299	$15.07	$64,785.93	23,988
6/17/2024	Tara Lynn Kieffer	Insider	Sell	7,266	$12.33	$89,589.78	32,341
12/13/2023	Terry Vance	Director	Sell	15,295	$9.12	$139,490.40	5,800
12/5/2023	Brendan Luu	VP	Sell	2,125	$9.63	$20,463.75	36,736
12/5/2023	Jay R. Luly	CEO	Sell	7,230	$9.63	$69,624.90	806,793
12/5/2023	Paul J Mellett	CFO	Sell	2,412	$9.63	$23,227.56	93,549
12/5/2023	Scott T Rottinghaus	CMO	Sell	534	$9.63	$5,142.42	26,466
3/15/2023	Paul J Mellett	CFO	Sell	10,440	$44.43	$463,849.20	97,556
3/15/2023	Yat Sun Or	VP	Sell	13,925	$44.45	$618,966.25	374,702
3/13/2023	Jay R. Luly	CEO	Sell	27,912	$45.16	$1,260,505.92	819,810
2/9/2023	Paul J Mellett	CFO	Sell	5,000	$53.76	$268,800.00	83,463
12/16/2022	Jay R. Luly	CEO	Sell	30,000	$44.72	$1,341,600.00	773,805
4/4/2022	Nathalie Adda	VP	Sell	32,785	$72.18	$2,366,421.30	34,982
4/1/2022	Nathalie Adda	VP	Sell	50,559	$71.23	$3,601,317.57	34,982
3/21/2022	Bruce L A Carter	Director	Sell	6,000	$67.83	$406,980.00
3/1/2022	Nathalie Adda	VP	Sell	24,339	$70.26	$1,710,058.14
1/11/2022	Nathalie Adda	VP	Sell	12,536	$70.13	$879,149.68
12/1/2021	Nathalie Adda	VP	Sell	13,523	$86.35	$1,167,711.05
11/1/2021	Nathalie Adda	VP	Sell	9,547	$84.89	$810,444.83
10/11/2021	Nathalie Adda	VP	Sell	4,047	$70.34	$284,665.98
10/8/2021	Nathalie Adda	VP	Sell	13,453	$70.09	$942,920.77
9/15/2021	Jay R. Luly	CEO	Sell	4,516	$59.06	$266,714.96

The next companies to potentially benefit thanks to Nvidia are …

From Weiss Ratings | Ad

Nvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And it’s enlisting a whole new set of partners.

Click here to learn more.

SEC Filings (Institutional Ownership Changes) for Enanta Pharmaceuticals (NASDAQ:ENTA)

94.99% of Enanta Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Enanta Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
7/26/2024	Allspring Global Investments Holdings LLC	2,667	$35K	0.0%	N/A	0.013%
7/26/2024	Bank of New York Mellon Corp	73,841	$0.96M	0.0%	+13.3%	0.349%
7/18/2024	Assenagon Asset Management S.A.	426,561	$5.53M	0.0%	-26.9%	2.014%
5/24/2024	Farallon Capital Management LLC	2,095,000	$36.58M	0.2%	+3.5%	9.891%
5/20/2024	Virtu Financial LLC	10,927	$0.19M	0.0%	N/A	0.052%
5/16/2024	California State Teachers Retirement System	2,037	$36K	0.0%	-38.1%	0.010%
5/16/2024	Jacobs Levy Equity Management Inc.	194,730	$3.40M	0.0%	-65.3%	0.919%
5/15/2024	Public Employees Retirement System of Ohio	7,662	$0.13M	0.0%	-76.3%	0.036%
5/10/2024	Acadian Asset Management LLC	853,896	$14.91M	0.1%	+1.3%	4.036%
5/10/2024	Vanguard Group Inc.	1,928,078	$33.66M	0.0%	+7.5%	9.114%
5/9/2024	State Board of Administration of Florida Retirement System	6,781	$0.12M	0.0%	N/A	0.032%
5/9/2024	Portland Global Advisors LLC	24,375	$0.43M	0.1%	-28.7%	0.115%
5/8/2024	Russell Investments Group Ltd.	19,213	$0.34M	0.0%	-19.9%	0.091%
5/7/2024	SG Americas Securities LLC	7,574	$0.13M	0.0%	-25.5%	0.036%
5/1/2024	BNP Paribas Financial Markets	24,683	$0.43M	0.0%	-50.1%	0.117%
4/17/2024	Hennion & Walsh Asset Management Inc.	13,689	$0.24M	0.0%	-13.1%	0.065%
2/14/2024	Pennant Investors LP	35,100	$0.33M	0.1%	N/A	0.166%
2/13/2024	Armistice Capital LLC	2,064,000	$19.42M	0.3%	-1.7%	9.754%
2/9/2024	Quest Partners LLC	15,465	$0.15M	0.0%	N/A	0.073%
2/9/2024	Trexquant Investment LP	118,612	$1.12M	0.0%	-10.5%	0.561%
2/7/2024	Jump Financial LLC	31,868	$0.30M	0.0%	-43.7%	0.151%
2/7/2024	BNP Paribas Financial Markets	49,459	$0.47M	0.0%	-10.8%	0.234%
2/1/2024	New York State Common Retirement Fund	7,772	$73K	0.0%	-23.1%	0.037%
1/31/2024	Federated Hermes Inc.	133,189	$1.25M	0.0%	N/A	0.629%
1/30/2024	Strs Ohio	18,700	$0.18M	0.0%	+20.6%	0.089%
1/25/2024	Nisa Investment Advisors LLC	2,827	$27K	0.0%	+417.8%	0.013%
1/17/2024	Assenagon Asset Management S.A.	583,658	$5.49M	0.0%	-7.6%	2.771%
1/12/2024	SG Americas Securities LLC	10,162	$96K	0.0%	-45.2%	0.048%
1/8/2024	Diversified Trust Co	16,900	$0.16M	0.0%	N/A	0.080%
12/18/2023	Vanguard Group Inc.	1,660,520	$18.55M	0.0%	-2.7%	7.885%
11/21/2023	Walleye Capital LLC	119,364	$1.33M	0.0%	+342.8%	0.567%
11/17/2023	Jacobs Levy Equity Management Inc.	345,651	$3.86M	0.0%	-0.5%	1.641%
11/15/2023	Krensavage Asset Management LLC	735,103	$8.21M	3.0%	+6.9%	3.491%
11/15/2023	Laurion Capital Management LP	11,287	$0.13M	0.0%	N/A	0.054%
11/15/2023	Armistice Capital LLC	2,100,000	$23.46M	0.4%	+3.1%	9.972%
11/14/2023	Caxton Associates LP	18,028	$0.20M	0.0%	N/A	0.086%
11/14/2023	Sherbrooke Park Advisers LLC	10,100	$0.11M	0.0%	N/A	0.048%
11/14/2023	Trexquant Investment LP	132,561	$1.48M	0.0%	N/A	0.629%
11/13/2023	Acadian Asset Management LLC	548,782	$6.13M	0.0%	+445.6%	2.606%
11/13/2023	Clearstead Advisors LLC	5,064	$57K	0.0%	N/A	0.024%
11/8/2023	Janney Montgomery Scott LLC	62,452	$0.70M	0.0%	N/A	0.297%
11/7/2023	Virtus ETF Advisers LLC	12,784	$0.14M	0.1%	-11.5%	0.061%
11/7/2023	Quantbot Technologies LP	7,200	$80K	0.0%	+2,300.0%	0.034%
11/7/2023	Clearstead Advisors LLC	5,064	$57K	0.0%	N/A	0.024%
11/7/2023	Barclays PLC	17,219	$0.19M	0.0%	-66.2%	0.082%
11/7/2023	Jump Financial LLC	56,636	$0.63M	0.0%	+41.5%	0.269%
11/6/2023	Assenagon Asset Management S.A.	631,626	$7.06M	0.0%	+613.6%	2.999%
10/27/2023	Hennion & Walsh Asset Management Inc.	28,034	$0.31M	0.0%	-7.8%	0.133%
10/24/2023	Bank of New York Mellon Corp	107,955	$1.21M	0.0%	-34.9%	0.513%
10/13/2023	SG Americas Securities LLC	18,546	$0.21M	0.0%	-68.9%	0.088%
10/10/2023	Daymark Wealth Partners LLC	10,000	$0.11M	0.0%	N/A	0.047%
9/21/2023	Barclays PLC	50,904	$1.09M	0.0%	+93.9%	0.242%
8/11/2023	Krensavage Asset Management LLC	687,613	$14.72M	4.7%	+14.0%	3.265%
8/10/2023	Profund Advisors LLC	17,594	$0.38M	0.0%	+65.9%	0.084%
8/9/2023	BNP Paribas Arbitrage SNC	46,853	$1M	0.0%	+102.3%	0.222%
8/9/2023	Commonwealth of Pennsylvania Public School Empls Retrmt SYS	22,372	$0.48M	0.0%	+7.6%	0.106%
8/8/2023	Rhumbline Advisers	64,744	$1.39M	0.0%	+1.4%	0.307%
8/7/2023	Principal Financial Group Inc.	115,487	$2.47M	0.0%	-5.0%	0.548%
8/7/2023	Acadian Asset Management LLC	100,581	$2.15M	0.0%	N/A	0.478%
8/3/2023	Barclays PLC	50,904	$1.09M	0.0%	+93.9%	0.242%
8/3/2023	Bank of New York Mellon Corp	165,793	$3.55M	0.0%	-1.1%	0.787%
7/31/2023	Strs Ohio	15,500	$0.33M	0.0%	+8.4%	0.074%
7/31/2023	Inspire Investing LLC	14,743	$0.32M	0.0%	+118.4%	0.070%
7/25/2023	Assenagon Asset Management S.A.	88,515	$1.89M	0.0%	-25.2%	0.420%
7/18/2023	Louisiana State Employees Retirement System	10,400	$0.22M	0.0%	+13.0%	0.049%
7/10/2023	SG Americas Securities LLC	59,635	$1.28M	0.0%	+40.6%	0.283%
5/16/2023	Armistice Capital LLC	2,012,000	$81.37M	1.2%	-3.2%	9.556%
5/15/2023	Commodore Capital LP	217,253	$8.79M	1.3%	-2.8%	1.032%
5/12/2023	Martingale Asset Management L P	21,364	$0.86M	0.0%	+2.4%	0.102%
5/12/2023	Dark Forest Capital Management LP	4,500	$0.18M	0.0%	+49,900.0%	0.022%
5/12/2023	Profund Advisors LLC	10,605	$0.43M	0.0%	N/A	0.051%
5/11/2023	ExodusPoint Capital Management LP	20,147	$0.82M	0.0%	N/A	0.096%
5/11/2023	Citigroup Inc.	50,420	$2.04M	0.0%	+3.8%	0.241%
5/11/2023	Skandinaviska Enskilda Banken AB publ	17,526	$0.71M	0.0%	-4.4%	0.084%
5/10/2023	Pictet Asset Management SA	270,853	$10.95M	0.0%	+271.4%	1.297%
5/9/2023	Principal Financial Group Inc.	121,603	$4.92M	0.0%	-0.6%	0.582%
5/9/2023	Portland Global Advisors LLC	34,175	$1.38M	0.2%	-5.6%	0.164%
5/9/2023	Bank of New York Mellon Corp	167,703	$6.78M	0.0%	-0.4%	0.803%
5/9/2023	Y Intercept Hong Kong Ltd	5,436	$0.22M	0.0%	+24.0%	0.026%
5/9/2023	Russell Investments Group Ltd.	24,125	$0.98M	0.0%	-1.9%	0.115%
5/8/2023	Zurcher Kantonalbank Zurich Cantonalbank	2,823	$0.11M	0.0%	-10.2%	0.014%
5/4/2023	Barclays PLC	26,250	$1.06M	0.0%	-48.4%	0.126%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	10,943	$0.44M	0.0%	N/A	0.052%
5/3/2023	Jump Financial LLC	15,968	$0.65M	0.0%	+94.3%	0.076%
5/2/2023	Yousif Capital Management LLC	9,516	$0.39M	0.0%	-17.9%	0.046%
5/2/2023	Amalgamated Bank	8,284	$0.34M	0.0%	-6.7%	0.040%
5/1/2023	Texas Permanent School Fund Corp	17,607	$0.71M	0.0%	+34.4%	0.084%
5/1/2023	Banque Pictet & Cie SA	11,594	$0.47M	0.0%	-31.2%	0.056%
4/28/2023	SG Americas Securities LLC	42,413	$1.72M	0.0%	+120.4%	0.203%
4/24/2023	Inspire Investing LLC	6,752	$0.27M	0.0%	+31.4%	0.032%
4/20/2023	Hennion & Walsh Asset Management Inc.	30,579	$1.24M	0.1%	-2.4%	0.146%
4/18/2023	Assenagon Asset Management S.A.	118,357	$4.79M	0.0%	+125.8%	0.567%
4/18/2023	ETF Managers Group LLC	7,080	$0.29M	0.0%	+36.5%	0.034%
4/13/2023	Allspring Global Investments Holdings LLC	2,532	$0.10M	0.0%	-27.1%	0.012%
3/23/2023	ETF Managers Group LLC	5,185	$0.24M	0.0%	-15.2%	0.025%
2/15/2023	Tang Capital Management LLC	200,000	$9.30M	1.4%	+45.2%	0.958%
2/15/2023	Armistice Capital LLC	2,078,000	$96.67M	1.7%	+0.3%	9.949%
2/15/2023	Braidwell LP	325,838	$15.16M	0.5%	N/A	1.560%
2/13/2023	Renaissance Technologies LLC	473,200	$22.01M	0.0%	+1.1%	2.265%
2/13/2023	Martingale Asset Management L P	20,863	$0.97M	0.0%	+21.6%	0.100%

Data available starting January 2016

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. The company has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. Enanta Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $15.52

$15.19

$15.82

50 Day Range

MA: $13.30

$11.43

$16.54

52 Week Range

Now: $15.52

$8.08

$20.04

Volume

92,016 shs

Average Volume

220,809 shs

Market Capitalization

$328.71 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.6

Who are the company insiders with the largest holdings of Enanta Pharmaceuticals?: Enanta Pharmaceuticals' top insider shareholders include:
Jay R Luly (CEO)
Yat Sun Or (VP)
Paul J Mellett (CFO)
Brendan Luu (VP)
Tara Lynn Kieffer (Insider)
Scott T Rottinghaus (CMO)
Scott T Rottinghaus (Insider)
Terry Vance (Director)
Learn More about top insider investors at Enanta Pharmaceuticals.
Who are the major institutional investors of Enanta Pharmaceuticals?: Enanta Pharmaceuticals' top institutional investors include:
Assenagon Asset Management S.A. — 2.01%
Bank of New York Mellon Corp — 0.35%
Allspring Global Investments Holdings LLC — 0.01%
Learn More about top institutional investors of Enanta Pharmaceuticals stock.
Which major investors are selling Enanta Pharmaceuticals stock?: During the last quarter, ENTA stock was sold by these institutional investors:
Assenagon Asset Management S.A.
In the last year, company insiders that have sold Enanta Pharmaceuticals company stock include:
Jay R Luly (CEO)
Yat Sun Or (VP)
Paul J Mellett (CFO)
Brendan Luu (VP)
Tara Lynn Kieffer (Insider)
Scott T Rottinghaus (CMO)
Scott T Rottinghaus (Insider)
Learn More investors selling Enanta Pharmaceuticals stock.
Which major investors are buying Enanta Pharmaceuticals stock?: During the previous quarter, ENTA stock was bought by institutional investors including:
Bank of New York Mellon Corp
Allspring Global Investments Holdings LLC